About ORDI
ORDI is a Healthcare company based in Bengaluru (India). Advocacy, support, and policy efforts for rare diseases in India. Its website ordindia.in draws about 13 thousand monthly visits. Its Indian entity Organization For Rare Diseases India. reported revenue of βΉ2.07 Cr. ORDI offers products and services including Rare Disease Advocacy and Helpline and Support Services. Its focus areas include Research and Development, Medical Research, Clinical Trials and Public Health.
Company details
ORD India is recognized as a national umbrella organization that was established as a non-profit company to represent the collective voice of patients with rare diseases in India. Efforts are focused on promoting public awareness, contributing to policy development such as the Rare Disease Policy, and facilitating collaborations with international forums like NORD and EURORDIS. Diagnosis and treatment options are accelerated through public-private partnerships, while clinical trials and research activities are encouraged to reduce inequalities for those affected.
- Headquarters Bengaluru, India
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website ordindia.in
- Social LinkedIn X Facebook Instagram
- Legal Name Organization For Rare Diseases India.
- Date of Incorporation 27 Mar, 2014
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹2.07 Cr
FY 2025 · -14% YoY
- Net Loss-₹3.5 Lakh
FY 2025 · -2% margin
- EBITDA-₹3.1 Lakh
FY 2025 · -1% margin
Associated legal entities of ORDI
ORDI operates through Organization For Rare Diseases India. (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Organization For Rare Diseases India. CIN U85100KA2014NPL074467 | Active | 27 Mar 2014 | Bangalore, Karnataka | ₹2.1 Cr | 4 | View details |
Products & Services of ORDI
ORDI offers a comprehensive portfolio of products and services, including Rare Disease Advocacy and Helpline and Support Services.
Advocacy services are provided to promote awareness and policy development for rare diseases.
Helpline and support services are offered to facilitate access to information and resources for patients.
Board of directors of Organization For Rare Diseases India. (ORDI)
Organization For Rare Diseases India. is the primary company behind ORDI. The board of Organization For Rare Diseases India. currently have 4 directors; the longest-serving is Sangeeta Ravindra Barde, appointed in 2014. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sangeeta Ravindra Barde DIN 00034810 | Director | 27 Mar 2014 | 12 yrs 7 mo | Organization For Rare Diseases India. |
| Prasannakumar Basayya Shirol DIN 05351127 | Director | 27 Mar 2014 | 12 yrs 7 mo | Organization For Rare Diseases India. |
| Ravinandan Mullahalli Eswaramurthy DIN 03266396 | Director | 27 Mar 2014 | 12 yrs 7 mo | Organization For Rare Diseases India. |
| Lalith Kumar Seetharaman DIN 08373166 | Director | 16 Apr 2019 | 7 yrs 6 mo | Organization For Rare Diseases India. |
Financials of ORDI
Figures of Organization For Rare Diseases India., the primary company behind ORDI, for FY 2025. Revenue was ₹2.07 Cr (-14% year on year). Net loss was -₹3.5 Lakh (-2% margin). EBITDA was -₹3.1 Lakh (-1% margin). Revenue has grown at a compounded annual rate of +37% over three years and +13% over five years.
- ₹2.07 CrRevenue · FY 2025 · -14% YoY
- -₹3.5 LakhNet loss · -2% margin
- -₹3.1 LakhEBITDA · -1% margin
- +37%Revenue CAGR, 3 years
- +13%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Organization For Rare Diseases India. are on its company page.
Detailed financial statements for ORDI
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of ORDI
The website of ORDI (ordindia.in) receives about 12.9K visits a month.
- Monthly visits12.9K
▲ 99% vs previous month
Websites whose visitors overlap most with ORDI. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
rarediseasesindia.org | rarediseasesindia.org | 100% | β | ||
rarediseases.in | rarediseases.in | 89% | #1,896,531 | β |
Top companies in Clinical Trials & Research Tech
2 companies that operate in the same segment as ORDI (Clinical Trials & Research Tech) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare. | 2004 | Ahmedabad, Gujarat, India | USD 50.52 M | 902 | ||
Generic injectables for oncology and anesthesiology are manufactured. | 1989 | Hyderabad, Telangana, India | USD 4.22 M | 228 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ORDI
ORDI is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
The primary company behind ORDI, Organization For Rare Diseases India., reported revenue of βΉ2.07 Cr for FY 2025, down 14% year on year.
ORD India is recognized as a national umbrella organization that was established as a non-profit company to represent the collective voice of patients with rare diseases in India. Efforts are focused on promoting public awareness, contributing to policy development such as the Rare Disease Policy, and facilitating collaborations with international forums like NORD and EURORDIS. Diagnosis and treatment options are accelerated through public-private partnerships, while clinical trials and research activities are encouraged to reduce inequalities for those affected.
ORDI offers Rare Disease Advocacy and Helpline and Support Services.
ORDI operates through Organization For Rare Diseases India..
The legal entities of ORDI currently have 4 directors, including Lalith Kumar Seetharaman, Sangeeta Ravindra Barde, Prasannakumar Basayya Shirol and others.
